Dare Bioscience Files Notice of Qualification
Ticker: DARE · Form: QUALIF · Filed: Apr 2, 2026 · CIK: 0001401914
Sentiment: neutral
Topics: regulation-a, qualification, pharmaceuticals
TL;DR
Dare Bioscience qualified for an offering on 4/1/26. Bullish.
AI Summary
Dare Bioscience, Inc. filed a Notice of Qualification (Form QUALIF) on April 1, 2026, under Regulation A. The filing indicates the company's qualification for a specific offering, with its principal business in Pharmaceutical Preparations.
Why It Matters
This filing signifies Dare Bioscience's official qualification for a securities offering, potentially enabling them to raise capital for their pharmaceutical development activities.
Risk Assessment
Risk Level: medium — Regulation A offerings can be complex and carry inherent risks related to capital raising and market reception.
Key Numbers
- 2026-04-01 — Qualification Date (Date of qualification for the offering)
- 024-12688 — File Number (Associated with the Regulation A filing)
Key Players & Entities
- Dare Bioscience, Inc. (company) — Filer
- 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 (address) — Mailing and Business Address
- 2834 (sic_code) — Pharmaceutical Preparations
FAQ
What type of securities offering is this qualification for?
The filing is a Notice of Qualification under Regulation A, indicating qualification for a specific securities offering.
When was Dare Bioscience, Inc. qualified?
Dare Bioscience, Inc. was qualified on April 1, 2026.
What is the primary business of Dare Bioscience, Inc. according to the filing?
The filing lists the SIC code as 2834, which corresponds to Pharmaceutical Preparations.
What is the CIK number for Dare Bioscience, Inc.?
The CIK number for Dare Bioscience, Inc. is 0001401914.
Where is Dare Bioscience, Inc. located?
The company's mailing and business address is 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122.
Filing Stats: 34 words · 1 min read · ~1 pages · Grade level 7.8 · Accepted 2026-04-02 00:15:02
Filing Documents
- primary_doc.html (QUALIF)
- primary_doc.xml (QUALIF) — 1KB
- 9999999994-26-000077.txt ( ) — 2KB
From the Filing
Notice of Qualification UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Qualification Date Qualified: April 1, 2026 4:01 P.M. Form: 1-A POS CIK: Company Name: Dare Bioscience, Inc. File Number: 024-12688